609 related articles for article (PubMed ID: 20089479)
1. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey.
Melzer D; Rice N; Depledge MH; Henley WE; Galloway TS
Environ Health Perspect; 2010 May; 118(5):686-92. PubMed ID: 20089479
[TBL] [Abstract][Full Text] [Related]
2. Association of Osteoarthritis with Perfluorooctanoate and Perfluorooctane Sulfonate in NHANES 2003-2008.
Uhl SA; James-Todd T; Bell ML
Environ Health Perspect; 2013 Apr; 121(4):447-52. PubMed ID: 23410534
[TBL] [Abstract][Full Text] [Related]
3. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000.
Calafat AM; Wong LY; Kuklenyik Z; Reidy JA; Needham LL
Environ Health Perspect; 2007 Nov; 115(11):1596-602. PubMed ID: 18007991
[TBL] [Abstract][Full Text] [Related]
4. Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure.
Gallo V; Leonardi G; Genser B; Lopez-Espinosa MJ; Frisbee SJ; Karlsson L; Ducatman AM; Fletcher T
Environ Health Perspect; 2012 May; 120(5):655-60. PubMed ID: 22289616
[TBL] [Abstract][Full Text] [Related]
5. Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Premature Ovarian Insufficiency in Chinese Women.
Zhang S; Tan R; Pan R; Xiong J; Tian Y; Wu J; Chen L
J Clin Endocrinol Metab; 2018 Jul; 103(7):2543-2551. PubMed ID: 29986037
[TBL] [Abstract][Full Text] [Related]
6. Association between serum perfluorinated chemicals and thyroid function in U.S. adults: the National Health and Nutrition Examination Survey 2007-2010.
Wen LL; Lin LY; Su TC; Chen PC; Lin CY
J Clin Endocrinol Metab; 2013 Sep; 98(9):E1456-64. PubMed ID: 23864701
[TBL] [Abstract][Full Text] [Related]
7. Maternal levels of perfluorinated chemicals and subfecundity.
Fei C; McLaughlin JK; Lipworth L; Olsen J
Hum Reprod; 2009 May; 24(5):1200-5. PubMed ID: 19176540
[TBL] [Abstract][Full Text] [Related]
8. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA.
Steenland K; Tinker S; Shankar A; Ducatman A
Environ Health Perspect; 2010 Feb; 118(2):229-33. PubMed ID: 20123605
[TBL] [Abstract][Full Text] [Related]
9. Perfluorooctane sulfonate and perfluorooctanoic acid in surgical thyroid specimens of patients with thyroid diseases.
Pirali B; Negri S; Chytiris S; Perissi A; Villani L; La Manna L; Cottica D; Ferrari M; Imbriani M; Rotondi M; Chiovato L
Thyroid; 2009 Dec; 19(12):1407-12. PubMed ID: 20001722
[TBL] [Abstract][Full Text] [Related]
10. Quantitative bias analysis of the association between subclinical thyroid disease and two perfluoroalkyl substances in a single study.
Dzierlenga MW; Moreau M; Song G; Mallick P; Ward PL; Campbell JL; Housand C; Yoon M; Allen BC; Clewell HJ; Longnecker MP
Environ Res; 2020 Mar; 182():109017. PubMed ID: 31865168
[TBL] [Abstract][Full Text] [Related]
11. Association between perfluoroalkyl acids and kidney function in a cross-sectional study of adolescents.
Kataria A; Trachtman H; Malaga-Dieguez L; Trasande L
Environ Health; 2015 Nov; 14():89. PubMed ID: 26590127
[TBL] [Abstract][Full Text] [Related]
12. Background levels of persistent organic pollutants in humans from Taiwan: perfluorooctane sulfonate and perfluorooctanoic acid.
Hsu JY; Hsu JF; Ho HH; Chiang CF; Liao PC
Chemosphere; 2013 Sep; 93(3):532-7. PubMed ID: 23886440
[TBL] [Abstract][Full Text] [Related]
13. Fetal exposure to perfluorinated compounds and attention deficit hyperactivity disorder in childhood.
Ode A; Källén K; Gustafsson P; Rylander L; Jönsson BA; Olofsson P; Ivarsson SA; Lindh CH; Rignell-Hydbom A
PLoS One; 2014; 9(4):e95891. PubMed ID: 24760015
[TBL] [Abstract][Full Text] [Related]
14. Tenuous dose-response correlations for common disease states: case study of cholesterol and perfluorooctanoate/sulfonate (PFOA/PFOS) in the C8 Health Project.
Kerger BD; Copeland TL; DeCaprio AP
Drug Chem Toxicol; 2011 Oct; 34(4):396-404. PubMed ID: 21770727
[TBL] [Abstract][Full Text] [Related]
15. Association among total serum isomers of perfluorinated chemicals, glucose homeostasis, lipid profiles, serum protein and metabolic syndrome in adults: NHANES, 2013-2014.
Liu HS; Wen LL; Chu PL; Lin CY
Environ Pollut; 2018 Jan; 232():73-79. PubMed ID: 28923343
[TBL] [Abstract][Full Text] [Related]
16. Association between perfluoroalkyl acids and the prevalence of hypertension among US adults.
Liao S; Yao W; Cheang I; Tang X; Yin T; Lu X; Zhou Y; Zhang H; Li X
Ecotoxicol Environ Saf; 2020 Jun; 196():110589. PubMed ID: 32278136
[TBL] [Abstract][Full Text] [Related]
17. The association between PFOA, PFOS and serum lipid levels in adolescents.
Geiger SD; Xiao J; Ducatman A; Frisbee S; Innes K; Shankar A
Chemosphere; 2014 Mar; 98():78-83. PubMed ID: 24238303
[TBL] [Abstract][Full Text] [Related]
18. Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population.
Innes KE; Wimsatt JH; Frisbee S; Ducatman AM
BMC Cancer; 2014 Jan; 14():45. PubMed ID: 24468211
[TBL] [Abstract][Full Text] [Related]
19. Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants.
Okada E; Sasaki S; Saijo Y; Washino N; Miyashita C; Kobayashi S; Konishi K; Ito YM; Ito R; Nakata A; Iwasaki Y; Saito K; Nakazawa H; Kishi R
Environ Res; 2012 Jan; 112():118-25. PubMed ID: 22030285
[TBL] [Abstract][Full Text] [Related]
20. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.
Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K
Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
